Measles cases are expected to continue increasing in the EU/EEA in the coming months due to sub-optimal vaccination coverage for measles-containing vaccines (MCV) in a number of EU/EEA countries.
Since the most recent ECDC rapid risk assessment in 2021, the number of EU/EEA countries reporting hypervirulent Klebsiella pneumoniae (hvKp) sequence type (ST) 23 has increased from four to ten and the number of cases reported to ECDC by the countries, increased from 12 to 143.
From 29 January to 2 February 2024, a team of experts from EC, ECDC, EFSA, Epiconcept and the Integrated Quality Laboratory Services (IQLS) will visit North Macedonia.
The European Respiratory Diseases Forecasting Hub (RespiCast) is open for weekly submission of several respiratory disease indicators such as influenza-like-illness, acute respiratory infection and COVID-19.
On 11 – 15 December 2023, MediPIET Cohort 5, EPIET, EUPHEM and PAE fellows attended the annual Time Series Analysis (TSA) module hosted by Instituto Superiore di Sanita (ISS) in Rome, Italy.
Several viral and bacterial respiratory pathogens are expected to continue co-circulating at variable levels during the coming months, and contribute to increased morbidity and mortality during this period. This is typical of every winter season.